We are live on ! Find out more
ALT icon

Altimmune

112 hedge funds and large institutions have $79.2M invested in Altimmune in 2023 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 27 increasing their positions, 40 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

138% more call options, than puts

Call options by funds: $2.13M | Put options by funds: $898K

7% less funds holding

Funds holding: 120112 (-8)

14.02% less ownership

Funds ownership: 71.55%57.53% (-14%)

30% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 23

33% less repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 40

36% less capital invested

Capital invested by funds: $125M → $79.2M (-$45.3M)

Holders
112
Holders Change
-8
Holders Change %
-6.67%
% of All Funds
1.78%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
16
Increased
27
Reduced
40
Closed
23
Calls
$2.13M
Puts
$898K
Net Calls
+$1.24M
Net Calls Change
+$197K
Name Holding Trade Value Shares
Change
Change in
Stake
UBS AM
126
UBS AM
Illinois
-$81K -19,200 Closed
State of Wisconsin Investment Board
127
State of Wisconsin Investment Board
Wisconsin
-$63.5K -18,000 Closed
State Board of Administration of Florida Retirement System
128
State Board of Administration of Florida Retirement System
Florida
-$49.5K -14,030 Closed
PMEF
129
Point72 Middle East FZE
United Arab Emirates
-$42.7K -12,097 Closed
P
130
Pitcairn
Pennsylvania
-$42.2K -11,960 Closed
AIM
131
Aigen Investment Management
New York
-$41.3K -11,712 Closed
Wolverine Trading
132
Wolverine Trading
Illinois
-$30.3K -10,553 Closed
UB
133
UMB Bank
Missouri
-$8.36K -2,368 Closed
FGAM
134
Financial Gravity Asset Management
Texas
-$9 -4 Closed

ALT Hedge Fund Activity: Q3 2023 in Review

112 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Altimmune (ALT) for Q3 2023, worth a combined $79.2M — down 36% from $125M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of ALT and 16 opened new positions — a net loss of 7 holders — while 40 trimmed existing stakes and 27 added.

The largest buyer was Prudential Financial, opening a new position worth an estimated $956K. The largest seller was Laurion Capital Management, cutting an estimated $2.95M.

  • 112 institutional investors held Altimmune (ALT) as of Q3 2023, down from 120 in Q2 2023.
  • Funds reported $79.2M of Altimmune stock for Q3 2023, down 36% quarter-over-quarter.
  • 16 funds opened new Altimmune positions in Q3 2023 and 23 closed out, a net change of -7 holders.
  • The largest Altimmune buyer in Q3 2023 was Prudential Financial, an estimated $956K added.
  • The largest Altimmune seller in Q3 2023 was Laurion Capital Management, an estimated $2.95M sold.

Based on aggregated 13F filings for Q3 2023.